Overview
Join us at Veeva R&D Summit, Europe on 18-20 May 2020 at the Palau de
Congressos de Catalunya, Barcelona to hear the latest news and market
trends in the industry, experience innovative technology and share best
practices.
Veeva R&D Summit, Europe is an annual gathering of pharma, biotech, and medical devices and diagnostics leaders in clinical, quality, regulatory, and IT.
This year, over 600 life sciences leaders and experts gathered at Veeva R&D’s Summit, Europe to hear from Merck, GSK, AstraZeneca, Novo Nordisk, LEO Pharma, and more. With over 30 breakout sessions featuring customer case studies in clinical, quality, regulatory, and IT there was something for everyone and 98% of attendees were satisfied with the event.
The conference is complimentary for Veeva customers and invited guests. Pre-register for next year today to secure your spot and mark this in your calendar.
Why Attend?
Find out how industry leaders are transforming the drug development process and how you can apply their learnings to your processes.
Veeva R&D Summit is the time to see the latest innovations and enhancements to improve operations across the drug development process.
Throughout our tracks and sessions, you’ll be able to connect with industry contacts who face the same challenges, share best practices and learnings, and strategize on your project’s next steps.
Visit the Veeva Booth to talk directly with Veeva product experts who can help solve your most pressing issues around content and data.
Attend exclusive customer community meetings at the close of Veeva R&D Summit where you’ll learn how to maximize your investment.
2019 Highlights
Enjoyed watching the video and want to know more? See the infographic on why delegates attend and dive deeper into this year’s conference and key takeaways below:
- Industry Experts Unite to Speed Drug Development – Chris Moore gives a high-level overview of 2019 Veeva R&D Summit, Europe. Read his blog to learn how companies are modernizing drug development and how to prepare a sangria using an SOP.
- Regulatory Transformation with Unified RIM – Paul Attridge and Katrin Spaepen provide key learnings from the regulatory track, with regulatory transformation stories from GSK, BMS, UCB, Norgine and GE Healthcare.
- Modernizing Quality Management – Robert Gaertner gives a recap of the quality track and looks at how cloud is enabling companies like Johnson and Johnson, UCB and, Horizon Therapeutics to gain greater end-to-end control.
- Optimizing Trial Performance with Unified Clinical – Jim Reilly looks at the clinical track and AstraZeneca’s journey to unified clinical operations.
